Previous close | 431.00 |
Open | 431.00 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 370.00 |
Expiry date | 2025-12-19 |
Day's range | 431.00 - 431.00 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Eli Lilly missed on total sales in the first quarter, but its GLP-1 drugs helped boost sales by 26% over those in Q1 2023.
Harness some of the world’s most powerful financial forces by combining compounding and dividends with conservative options strategies.
Unveiling the Financial and Strategic Position of Eli Lilly and Co in 2024